Skip to main content
. 2022 Dec 13;13:1090958. doi: 10.3389/fneur.2022.1090958

Figure 2.

Figure 2

ROC curve of HCY in serum (A), methylmalonic acid in urine (B), methylmalonic acid in serum (C), methylmalonic acid in serum total exosomes (D), methylmalonic acid in serum neuro-exosomes (E) individually for distinguishing HHcy patients and cblC-MMA patients with cognitive impairment. ROC, receiver operating characteristic; HCY, homocysteine; neuro-exosomes, neuronal-derived exosomes; HHcy, non-inherited hyperhomocysteinemia.